The CRO That Solves Oncology Trial Challenges.
Reliable, flexible, and built for global trials — Biorasi brings cancer therapies to patients faster.
Why Biorasi For Oncology?
When cancer trials require strategic precision, sponsors turn to Biorasi. We combine oncology-specific experience, global reach, and agile execution to overcome barriers and hit milestones on time, every time.
Subspecialties
- Solid Tumors
- Hematologic Malignancies
- Rare Cancers
Proof of Performance
- 24 Oncology Studies
- 19 Indications
- 194 Sites Activated
- 1,146 Patients Enrolled
THE BIORASI ADVANTAGE
ONCOLOGY EXPERIENCE
Proven strategies even in rare and hard-to-reach populations
REGULATORY EXPERTISE
Oncology-focused regulatory insights with FDA, EMA, and global compliance
GLOBAL REACH
Access to patients and clinical sites across 48 countries
FROM OUR PARTNERS
“Working with the Biorasi team was an incredible experience. As our lead CRO, they managed every aspect of our clinical study — from design and conduct to monitoring, data management, and final data delivery.”
From the Library
Article
Biorasi Center of Excellence Spotlight: Oncology
Article
Biorasi Meets First Patient, First Visit Milestone for Dermatology Trial During COVID-19
Article
Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020
Article